-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top Innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...
More »SEARCH RESULT
House panel: Government clearing harmful drugs -Rupali Mukherjee
-The Times of India MUMBAI: You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with "dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing...
More »A Smartphone That Converts Text to Braille Developed for the Blind -Rutu Ladage
-India Times An Indian has developed a unique smart-phone that can aid the blind and help them perform functions other than answering calls. Technology has definitely been a blessing to humans and smartphones have become the need of the day. With having everything from the daily wake-up call (read alarm) to good-night reads (ebooks) on your phone, it has become an essential, almost a basic need. However, there is a segment of population...
More »Indian patent rulings may face legal heat internationally -Soma Das
-The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned. An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon...
More »New mechanism: price of cancer drugs set to fall -Himani Chandna Gurtoo
-The Hindustan Times Cancer drugs will cost almost 25% less if the regulator implements a new formula that calls for a price cap. The price regulator National Pharmaceutical Pricing Authority (NPPA) is considering a pricing mechanism similar to the one for insulin products - which has brought down prices by up to 40% - for 33 cancer drugs, most of them generics. Basically, the lowest price from the list of drugs in a...
More »